Developers: | OrthoPediatrics |
Date of the premiere of the system: | January, 2021 |
Branches: | Pharmaceutics, medicine, health care |
2021: The announcement of implants of OrthoPediatrics Femur for treatment of incorrectly spliced bones at children
At the beginning of January, 2021 the OrthoPediatrics company released the first implants in sterile packaging for treatment of incorrectly spliced bones at children using the pediatric Femur platform.
A system is intended for treatment of children with femur diaphysis changes, subvertelny fractures of a femur, ipsilateralny changes of a neck/diaphysis of a femur, for prevention of the approaching pathological changes, for correction of not unions, the wrong unions and for fixing of the femurs prepared for deformation correction.
A system is available in children's and teenage configurations. Children's rods for fixing are with a diameter of 7 mm, 8 mm and 9 mm. Diameter of rods for teenagers is 9 mm, 10 mm, 11 mm and 12 mm. Length of rods fluctuates from 20 cm to 42 cm depending on diameter. Versions of the proximal and disteel blocking screws are also provided in a system. Around the world the Femur platform from the moment of its release in 2018 already helped with treatment of more than 1000 children.
Implementation of sterile implants represents important addition to our portfolio, - the vice president for correction of injuries and deformations of OrthoPediatrics Joe Hauser in the press release said. - Our sterile implants can bring special benefit to clients. We approved new design with clients to reduce the total area occupied by our systems without loss of intraoperative efficiency. |
With the advent of sterile implants the Femur system found new features and provided additional opportunities to surgeons. Now the most complete range of implants will be available to pediatrics of Femur in a sterile type in separate packagings. It will help hospitals to increase safety of patients and to improve tracking of use of implants, at the same time reducing loading and costs for departments of sterile processing.[1]